One to Watch: Aerovate Therapeutics
AVTE to gap fill?? Possibly going back to $32 from ... 2 one to keep on the watchlistBiotech alert! Aerovate Therapeutics is working on a treatment for rare lung diseases, specifically pulmonary arterial hypertension. Founded in 2018, this MA-based company is one to watch! #biotech #AerovateTherapeutics
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.